Chris Neumann

Chris Neumann is a Senior Director and Head of ADC Chemistry, currently serving at Pfizer. They held roles as Associate Director and Senior Scientist at Seattle Genetics from 2020 to 2022, where they led a team focused on developing new chemical technologies for antibody-drug conjugates. Previously, Chris was a Research Assistant Professor at the University of Washington, contributing to the biosynthesis of small molecules. They earned a PhD in Chemistry from Harvard University, following a BA in Chemistry from Rice University, and completed a postdoctoral fellowship at Harvard Medical School.